From the Editorial Board: Robert W. Dubois, MD, PhD
From the Editorial Board, July 2019: Robert W. Dubois, MD, PhD
US Care Pathways: Continued Focus on Oncology and Outstanding Challenges
The authors examined the latest trends in development, implementation, and evaluation of care pathways and the impact of the movement toward value-based care.
Value-Based Arrangements May Be More Prevalent Than Assumed
We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.
Solutions for Filling Gaps in Accountable Care Measure Sets
Gaps in accountable care measure sets can be addressed efficiently using priority measure types and innovative approaches to measurement.
Developing Evidence That Is Fit for Purpose: A Framework for Payer and Research Dialogue
A decision-making framework that can be used to harmonize the evidence payer's desire for coverage and formulary decisions with the evidence generated by researchers.
Private Sector Risk-Sharing Agreements in the United States: Trends, Barriers, and Prospects
Assessment of current trends, success factors, and challenges in the use of risk-sharing agreements in the US private sector.
Individual Treatment Effects: Implications for Research, Clinical Practice, and Policy
A framework for researchers, providers, payers, or public health bodies identifies when it is most critical to distinguish between "average" population and individual patient response.
Role of Pharmaceuticals in Value-Based Healthcare: A Framework for Success
A framework for the role of pharmaceuticals in value-based healthcare, practical examples from organizations that have made the transition, and implementation considerations.
Growth in Use of Lipid-lowering Therapies: Are We Targeting the Right Patients?
Gastrointestinal Illness in Managed Care: Healthcare Utilization and Costs
